Delivery Order SPE2DB24D1021-SPE2DB25FEZFM
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order on June 25, 2025, by the Defense Logistics Agency for 500 tablets of Topiramate 25 mg, a generic anticonvulsant and migraine prevention medication commonly used in military and veteran healthcare systems. The delivery order, valued at $19,617.80 with firm fixed pricing, is non-competitive and was issued as a child contract under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of...
- The Defense Logistics Agency awarded a $32,008.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 500 tablets of Topiramate 25 mg on September 5, 2025, with an ultimate completion date of September 8, 2025. This delivery order was issued without a set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be delivered to the company's headquarters location in Conshohocken, Pennsylvania. Topiramate is an anticonvulsant medication commonly...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of 500 tablets of Topiramate 25 mg at a ceiling value of $8,738.79. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award to this qualified pharmaceutical distributor. The contract is set for completion by September 15, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $5,177.90 to AmerisourceBergen Drug Corp for the supply of 500 tablets of Topiramate 25 mg. This contract, which was competitively awarded without set-aside designation, represents a firm fixed-price delivery order with an ultimate completion date of June 6, 2025. The vendor, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This award is a child contract derived from...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Topiramate 25 mg tablets in quantities of 500 units, with a contract ceiling value of $7,555.16. This is a firm fixed-price delivery order with an ultimate completion date of September 17, 2025, and represents a non-set-aside competitive award. The delivery location is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $9,477.80 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of 500 tablets of Topiramate 25 mg, a neurological medication commonly used to treat epilepsy and migraine prevention. This is a firm fixed price, non-set-aside contract with performance to be completed by August 19, 2025, and fulfillment occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Topiramate 25 mg tablets in quantities of 500 units, with a ceiling value of $4,748.01 and an ultimate completion date of August 1, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order valued at $1,032.61 to AmerisourceBergen Drug Corp for 500 tablets of Topiramate 25 mg. The contract, which became effective on August 18, 2025, with an ultimate completion date of August 19, 2025, utilizes firm fixed price pricing and was awarded without a set-aside designation. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $3,273.32 delivery order to AmerisourceBergen Drug Corp for Topiramate ER 100 mg capsules (30-count) on August 13, 2025, with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Topiramate is a generic anticonvulsant and mood-stabilizing medication commonly used in military and...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Topiramate 25 mg tablets in quantities of 500 units. This non-set-aside, competitively awarded contract carries a ceiling value of $59,501.78 under a firm fixed-price arrangement, with an ultimate completion date of August 27, 2025. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FEZFMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of 1,000 tablets of Topiramate 50 mg, a generic anticonvulsant medication commonly used for seizure management and migraine prevention. This firm fixed-price delivery order, valued at $1,005.84, is set to be completed by August 5, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vehicle designated SPE2DX that runs through December 2026 and serves as a comprehensive global pharmaceutical support mechanism for military healthcare systems worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, holds significant standing as a federal medical procurement vendor for military and veteran healthcare systems. The company was competitively awarded this non-set-aside delivery order, consistent with its portfolio of federal contract awards demonstrating capability to fulfill diverse pharmaceutical supply requirements for the Defense Logistics Agency's Medical Supply Chain. This award exemplifies the company's role in supporting federal medical procurement across multiple therapeutic domains, delivering critical pharmaceutical commodities to sustain military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 8/4/25 |